← Back to list
New and Emerging Medical Technologies and Procedures
Effective date
Oct 1, 2026
Identified
Jun 16, 2026
Summary
New and emerging medical technologies and procedures listed in this policy are considered investigational because current scientific evidence is not yet sufficient to establish their impact on health outcomes. The listed services include many CPT codes across imaging, implant, cardiac device, bone assessment, neurostimulation, and oncology algorithm analysis, several tied to named manufacturers. Contracts exclude from coverage services or procedures that are considered investigational, and providers may bill members for them.
Get alerts when payers change rules like this one
We check Regence BlueShield and other payers every day and email you when a change matches your specialty and state.
Get Regence BlueShield alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01Already effective October 1, 2026: Billing team: Check the member's contract language, which takes precedence over the medical policy, before billing any code on this investigational list, including the CPT codes in the policy's code table.
02Codes 0623T, 0624T, 0625T, 0626T and 0631T are marked as deleted 01/01/2026 in the policy.
03Providers: Before rendering these services, inform members that they are likely financially responsible for the cost, since providers are encouraged to do so and may bill members for investigational services.
Codes mentioned
83951C1824C8001C8003K1030L8605
Original notice
New and Emerging Medical Technologies and Procedures
beonbrand.getbynder.com · Always check the source before changing claims.